Entity
The Access Challenge
Up & running (A)
Existing signals show a regular activitySocial networks
1,209 810Activities
Entity types
Location
215 Park Ave S, New York, NY 10003, USA
New York
United States of America
Employees
Scale: 11-50
Estimated: 11
Engaged catalyst
7
0 0Added in Motherbase
5 years, 11 months ago
Description
Value proposition
Building momentum in Africa for Universal Health Coverage. Health should not be a luxury. #OnebyOne2030 #UHC
We are advocates for Universal Access to healthcare and education. We work with governments, businesses, and cultural leaders to effectuate policy changes.
advocacy, Public Health, Communications, and Public Policy
Access Challenge
THE ACCESS CHALLENGE works with national leaders to advocate for equal access to healthcare and education for the world's most underserved populations.
https://www.accesschallenge.org - Website is disabled or domain is for sale
Catalyst interactions
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 UN Africa Renewal International development, International Affairs | UN Africa Renewal International development, International Affairs | Other 30 Nov 2024 | | |
 Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Other 30 Sep 2024 | | |
 Financial Times Media, Newspaper Publishing | Financial Times Media, Newspaper Publishing | Other 3 Oct 2019 | | |
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 25 Sep 2018 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 15 Sep 2018 | | |
 Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 6 Jun 2019 | | |
 Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 18 Sep 2019 | | |
Social network dynamics
Last news Show all articles
Loading...